Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
17 hedge funds and large institutions have $18.2M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
21% more funds holding
Funds holding: 14 → 17 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less capital invested
Capital invested by funds: $26.4M → $18.2M (-$8.18M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$50.1K |
| 2 |
OAMG
Odey Asset Management Group
London,
United Kingdom
|
+$19.1K |
| 3 |
Millennium Management
New York
|
+$16.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.1K |
| 5 |
Morgan Stanley
New York
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$18.6K |
| 2 |
Renaissance Technologies
New York
|
-$11.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$8K |
| 4 |
Two Sigma Investments
New York
|
-$4.64K |
| 5 |
HCA
Harbor Capital Advisors
Chicago,
Illinois
|
-$1.77K |
FRLN Hedge Fund Activity: Q4 2022 in Review
17 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q4 2022, worth a combined $18.2M — down 31% from $26.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FRLN positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $50.1K. The largest seller was Eventide Asset Management, cutting an estimated $18.6K.
- 17 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q4 2022, up from 14 in Q3 2022.
- Funds reported $18.2M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q4 2022, down 31% quarter-over-quarter.
- 4 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q4 2022 and 1 closed out, a net change of +3 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q4 2022 was Thrivent Financial for Lutherans, an estimated $50.1K added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q4 2022 was Eventide Asset Management, an estimated $18.6K sold.
Based on aggregated 13F filings for Q4 2022.